Posted on 2/20/20
Ribbon Communications Appoints Stewart Ewing and Krish Prabhu to Board
Ribbon Communications Inc. (Nasdaq: RBBN), a global software leader in secure and intelligent cloud communications, today announced the appointment of Stewart Ewing
Posted on 2/19/20
Aternity Names Bill Hewitt CEO
Aternity®, the enterprise-class Digital Experience Management Company™, today announced that Bill Hewitt has been appointed
Posted on 2/18/20
Trevi Therapeutics Appoints James Cassella, Ph.D. to Board
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine
Posted on 2/18/20
PASSUR Aerospace Announces the Appointment of Brian Cook as Chief Executive Officer
PASSUR Aerospace, Inc. (OTC: PSSR), a global leader in digital aviation operational excellence and predictive analytics, announced that Brian Cook
Posted on 2/18/20
Akcea Appoints Amber Salzman to Board
Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., today announced the appointment of Amber Salzman, Ph.D., to the Company’s Board
Posted on 2/18/20
Kleo Pharmaceuticals Elects Doug Manion as Chairman of the Board
Kleo Pharmaceuticals, Inc., an immuno-oncology company developing next-generation, fully synthetic bispecific compounds designed to emulate or enhance the activity
Posted on 2/14/20
Phil Snow Joins Quantopian’s Board of Directors
BOSTON, Feb. 11, 2020 (GLOBE NEWSWIRE) -- Quantopian today announced that Phil Snow, CEO of FactSet, has joined Quantopian’s Board of Directors on December 19, 2019. . . .
Posted on 2/14/20
Yield10 Bioscience Appoints Sherri Brown, Ph.D., to Board of Directors
Yield10 Bioscience, Inc. (Nasdaq:YTEN today announced that Sherri M. Brown, Ph.D. was appointed to the Company’s Board of Directors effective February 11, 2020.
Posted on 2/13/20
Akcea Therapeutics Appoints Dr. Amber Salzman to Board
Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., today announced the appointment of Amber Salzman, Ph.D., to the Company’s Board of Directors
Posted on 2/13/20
Anika Therapeutics Names Dr. Cheryl Blanchard as Interim CEO
Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that Dr. Cheryl Blanchard, a member of the Company’s Board of Directors since August 2018,
Posted on 2/12/20
ONS Names Tim Corvino, M.D., CEO
Orthopaedic & Neurosurgery Specialists (ONS), one of the nation’s leading providers of orthopaedic and neurosurgery services
Posted on 2/12/20
Axial Biotherapeutics Strengthens and Expands Board of Directors and Leadership Team
Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases
Posted on 2/12/20
Fuze’s Timothy Puccio Named to CRN’s 2020 Channel Chiefs List
BOSTON--(BUSINESS WIRE)--Fuze, the leading cloud-based communications provider for the modern global enterprise, announced today that CRN®, a brand of The Channel Company, has named Timothy Puccio, . . .
Posted on 2/12/20
InsideTracker Appoints Dr. Emil Chiauzzi, PhD to its Scientific Advisory Board
InsideTracker, a leading platform for ultra-personalized nutrition, health and wellness, has announced that Dr. Emil Chiauzzi has joined the company's
Posted on 2/11/20
Kopin CEO John C.C. Fan Named to National Academy of Engineering
WESTBOROUGH, Mass.--(BUSINESS WIRE)--Kopin Corporation (NASDAQ: KOPN), a leading developer of innovative wearable computing technologies and solutions, announced that its CEO, Dr. John C.C. Fan, has been . . .
Posted on 2/10/20
Nantero Appoints Rob Sprinkle To Its Advisory Board
Nantero Inc., the nanotechnology company developing next-generation memory using carbon nanotubes, today announced that it has appointed Rob Sprinkle
Posted on 2/10/20
Dicerna Appoints Stephen Doberstein, Ph.D., to Board of Directors
Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics
Posted on 2/10/20
IM Therapeutics Appoints Dr. Stephen Dilly to Board of Directors
ImmunoMolecular Therapeutics, Inc., a clinical stage company developing personalized therapies for autoimmune disease
Posted on 2/10/20
Kelly Ortberg Appointed Special Advisor to Office of the CEO
United Technologies Corp. (NYSE: UTX) today announced that Kelly Ortberg has been named special advisor to the Office of the CEO
Posted on 2/10/20
GreenLight Taps Health Care Experts to Join Life Sciences Advisory Board
As part of its expansion into human health, GreenLight Biosciences, Inc. is pleased to welcome the first members of its new Life Sciences Advisory Board.
Posted on 2/6/20
Fusion Pharmaceuticals Appoints Pablo Cagnoni to Board
Fusion Pharmaceuticals Inc., a clinical-stage precision oncology company developing targeted alpha therapeutics, today announced the appointment of Pablo J. Cagnoni, M.D.,
Posted on 2/5/20
BR Brands Appoints Jacques Panis as Mary's Brands Chief Executive Officer
BR Brands, LLC, a consumer packaged goods company within the global legal cannabis industry, announced today that Jacques Panis has been appointed Chief Executive Officer of . . .
Posted on 2/5/20
World Congress Appoints New CEO, Benny DiCecca
World Congress Research (World Congress), a premier conference company known for its content and thought-leadership in the Health Care, Life Sciences
Posted on 2/5/20
Everbridge Appoints Finastra CEO Simon Paris to its Board of Directors
Everbridge, Inc. (NASDAQ: EVBG), the global leader in critical event management (CEM), today announced the appointment of Simon Paris to the Everbridge Board of Directors.
Posted on 2/4/20
ROVA Appoints Steven Hoffman to Board of Advisors
?ROVA, a revolutionary on-demand delivery platform which has officially launched in the Boston market
Boston
